Challenges and opportunities for translating medical microdevices: Insights from the programmable bio-nano-chip

Michael P. McRae, Glennon Simmons, John McDevitt

Research output: Contribution to journalArticle

Abstract

This perspective highlights the major challenges for the bioanalytical community, in particular the area of lab-on-a-chip sensors, as they relate to point-of-care diagnostics. There is a strong need for general-purpose and universal biosensing platforms that can perform multiplexed and multiclass assays on real-world clinical samples. However, the adoption of novel lab-on-a-chip/microfluidic devices has been slow as several key challenges remain for the translation of these new devices to clinical practice. A pipeline of promising medical microdevice technologies will be made possible by addressing the challenges of integration, failure to compete with cost and performance of existing technologies, requisite for new content, and regulatory approval and clinical adoption.

Original languageEnglish (US)
Pages (from-to)905-919
Number of pages15
JournalBioanalysis
Volume8
Issue number9
DOIs
StatePublished - May 1 2016

Fingerprint

Lab-on-a-chip
Lab-On-A-Chip Devices
Point-of-Care Systems
Technology
Microfluidics
Assays
Pipelines
Costs and Cost Analysis
Equipment and Supplies
Sensors
Costs

Keywords

  • lab-on-a-chip
  • mHealth
  • microfluidic devices
  • point-of-care diagnostics
  • programmable bio-nano-chip (p-BNC)

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Medical Laboratory Technology
  • Analytical Chemistry

Cite this

Challenges and opportunities for translating medical microdevices : Insights from the programmable bio-nano-chip. / McRae, Michael P.; Simmons, Glennon; McDevitt, John.

In: Bioanalysis, Vol. 8, No. 9, 01.05.2016, p. 905-919.

Research output: Contribution to journalArticle

@article{2ad5c1a5f7f1467e837c61b47ee71fb2,
title = "Challenges and opportunities for translating medical microdevices: Insights from the programmable bio-nano-chip",
abstract = "This perspective highlights the major challenges for the bioanalytical community, in particular the area of lab-on-a-chip sensors, as they relate to point-of-care diagnostics. There is a strong need for general-purpose and universal biosensing platforms that can perform multiplexed and multiclass assays on real-world clinical samples. However, the adoption of novel lab-on-a-chip/microfluidic devices has been slow as several key challenges remain for the translation of these new devices to clinical practice. A pipeline of promising medical microdevice technologies will be made possible by addressing the challenges of integration, failure to compete with cost and performance of existing technologies, requisite for new content, and regulatory approval and clinical adoption.",
keywords = "lab-on-a-chip, mHealth, microfluidic devices, point-of-care diagnostics, programmable bio-nano-chip (p-BNC)",
author = "McRae, {Michael P.} and Glennon Simmons and John McDevitt",
year = "2016",
month = "5",
day = "1",
doi = "10.4155/bio-2015-0023",
language = "English (US)",
volume = "8",
pages = "905--919",
journal = "Bioanalysis",
issn = "1757-6180",
publisher = "Future Science",
number = "9",

}

TY - JOUR

T1 - Challenges and opportunities for translating medical microdevices

T2 - Insights from the programmable bio-nano-chip

AU - McRae, Michael P.

AU - Simmons, Glennon

AU - McDevitt, John

PY - 2016/5/1

Y1 - 2016/5/1

N2 - This perspective highlights the major challenges for the bioanalytical community, in particular the area of lab-on-a-chip sensors, as they relate to point-of-care diagnostics. There is a strong need for general-purpose and universal biosensing platforms that can perform multiplexed and multiclass assays on real-world clinical samples. However, the adoption of novel lab-on-a-chip/microfluidic devices has been slow as several key challenges remain for the translation of these new devices to clinical practice. A pipeline of promising medical microdevice technologies will be made possible by addressing the challenges of integration, failure to compete with cost and performance of existing technologies, requisite for new content, and regulatory approval and clinical adoption.

AB - This perspective highlights the major challenges for the bioanalytical community, in particular the area of lab-on-a-chip sensors, as they relate to point-of-care diagnostics. There is a strong need for general-purpose and universal biosensing platforms that can perform multiplexed and multiclass assays on real-world clinical samples. However, the adoption of novel lab-on-a-chip/microfluidic devices has been slow as several key challenges remain for the translation of these new devices to clinical practice. A pipeline of promising medical microdevice technologies will be made possible by addressing the challenges of integration, failure to compete with cost and performance of existing technologies, requisite for new content, and regulatory approval and clinical adoption.

KW - lab-on-a-chip

KW - mHealth

KW - microfluidic devices

KW - point-of-care diagnostics

KW - programmable bio-nano-chip (p-BNC)

UR - http://www.scopus.com/inward/record.url?scp=84968831102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968831102&partnerID=8YFLogxK

U2 - 10.4155/bio-2015-0023

DO - 10.4155/bio-2015-0023

M3 - Article

C2 - 27071710

AN - SCOPUS:84968831102

VL - 8

SP - 905

EP - 919

JO - Bioanalysis

JF - Bioanalysis

SN - 1757-6180

IS - 9

ER -